Skip to content

Author

R. López-Vilella

We have 3 of 115 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Anticoagulation strategies during peripheral ultrafiltration in diuretic-resistant congestive heart failure.

Introduction and objectives Peripheral ultrafiltration (UF) is an effective strategy for the management of diuretic-resistant congestion in patients with decompensated heart failure. However, extracorporeal circuit clotting remains one of the main technical limitations of the procedure, and the optimal anticoagulation...

B. G. Cervera, R. López-Vilella, Valero Vicente Soriano Alfonso et al. · 0 citations
Open access Oct 2026

Phenotypic characterization of pulmonary hypertension associated with left heart disease in contemporary practice: insights from the Re-PHIRE Trial

The Re-PHIRE trial provides one of the largest contemporary multi-country cohorts of patients with RHC-confirmed diagnosis of PH-LHD across the EF continuum and a wide PVR range, thereby capturing a spectrum of haemodynamic and clinical phenotypes.

E. Surkova, M. Ufnal, M. Ciurzyński et al. · 0 citations
Open access Sep 2026

Decisions in Diuretic Resistance: Oral or Subcutaneous Furosemide in Advanced Ambulatory Heart Failure?

In this exploratory real-world cohort of patients with advanced HF and refractory congestion, both outpatient furosemide strategies were associated with short-term decongestion, with differences observed in symptomatic response.

R. López-Vilella, Borja Guerrero Cervera, Emilio Monte Boquet et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.